These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 20038285)

  • 1. [Thienopyridines in the treatment and prevention of cardiovascular diseases. III. therapeutic application of clopidogrel as monotherapy (without acetylsalicylic acid)].
    Preobrazhenskiĭ DV; Sidorenko BA; Batyraliev TA; Vural A; Islek M; Avsar O; Fettser DV
    Kardiologiia; 2009; 49(12):63-7. PubMed ID: 20038285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Thienopyridines in the treatment and prevention of cardiovascular diseases. Part V. Combination of clopidogrel and acetylsalicylic acid in the treatment of stable patients with atherothrombotic cardiovascular diseases].
    Preobrazhenskiĭ DV; Sidorenko BA; Fettser DV; Batyraliev TA; Niiazova-Karben ZA; Besnili F
    Kardiologiia; 2010; 50(5):73-6. PubMed ID: 20831051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clopidogrel and ticlopidine: P2Y12 adenosine diphosphate-receptor antagonists for the prevention of atherothrombosis.
    Savi P; Herbert JM
    Semin Thromb Hemost; 2005 Apr; 31(2):174-83. PubMed ID: 15852221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Thienopyridines in the treatment and prevention of cardiovascular diseases. Part IV. therapeutic application of clopidogrel in combination with acetylsalicylic acid in acute coronary syndromes and percutaneous coronary interventions].
    Preobrazhenskiĭ DV; Sidorenko BA; Batyraliev TA; Vural A; Islek M; Avsar O; Fettser DV
    Kardiologiia; 2009; 49(12):68-74. PubMed ID: 20038286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of adenosine 5'-diphosphate receptor blockade in patients with cardiovascular disease.
    Solet DJ; Zacharski LR; Plehn JF
    Am J Med; 2001 Jul; 111(1):45-53. PubMed ID: 11448660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Thienopyridines in the treatment and prevention of cardiovascular diseases. Part I. Ticlopidine].
    Fettser DV; Preobrazhenskiĭ DV; Batyraliev TA; Sidorenko BA; Pataraia SA
    Kardiologiia; 2009; 49(4):72-83. PubMed ID: 19463124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ticlopidine and clopidogrel.
    Quinn MJ; Fitzgerald DJ
    Circulation; 1999 Oct; 100(15):1667-72. PubMed ID: 10517740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thienopyridines in the treatment and prevention of cardiovascular diseases. Part II. Clinical pharmacology of clopidogrel].
    Preobrazhenskiĭ DV; Sidorenko BA; Batyraliev TA; Vural A; Islek M; Avsar O
    Kardiologiia; 2009; 49(10):88-96. PubMed ID: 19845526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL; Malinin AI; Pokov AN; Hanley DF
    Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ticagrelor--a new platelet aggregation inhibitor in patients with acute coronary syndromes. An improvement of other inhibitors?
    Kowalczyk M; Banach M; Mikhailidis DP; Hannam S; Rysz J
    Med Sci Monit; 2009 Dec; 15(12):MS24-30. PubMed ID: 19946242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in antiplatelet therapy for stroke prevention: the new P2Y12 antagonists.
    Giossi A; Pezzini A; Del Zotto E; Volonghi I; Costa P; Ferrari D; Padovani A
    Curr Drug Targets; 2010 Mar; 11(3):380-91. PubMed ID: 20210760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet function analysis: at the edge of meaning.
    Oestreich JH; Smyth SS; Campbell CL
    Thromb Haemost; 2009 Feb; 101(2):217-9. PubMed ID: 19190799
    [No Abstract]   [Full Text] [Related]  

  • 13. [The value of platelet inhibitors in the secondary prophylaxis of stroke -- a review].
    Schellinger PD; Jüttler E; Meyding-Lamadé UK; Schwark C
    Fortschr Neurol Psychiatr; 2004 May; 72(5):270-81. PubMed ID: 15136948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination antiplatelet agents for secondary prevention of ischemic stroke.
    Vande Griend JP; Saseen JJ
    Pharmacotherapy; 2008 Oct; 28(10):1233-42. PubMed ID: 18823219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antithrombotic therapy after cerebral ischemia].
    Schellinger PD; Orberk E; Hacke W
    Fortschr Neurol Psychiatr; 1997 Sep; 65(9):425-34. PubMed ID: 9417427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of the cardiac triple therapy: the experience of the Quebec Heart Institute.
    Brulotte S; Sénéchal M; Poirier P; Nguyen CM; Lemieux A; Magne J; Bergeron S
    Can J Cardiol; 2007 Oct; 23 Suppl B(Suppl B):80B-83B. PubMed ID: 17932593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clopidogrel and [symbol: see text] ticlopidine--improvements on aspirin?
    Drug Ther Bull; 1999 Aug; 37(8):59-61. PubMed ID: 10696686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced antiplatelet effects of clopidogrel plus acetylsalicylic acid compared with acetylsalicylic acid alone or combined with extended-release dipyridamole in healthy volunteers.
    Caplain H
    Cerebrovasc Dis; 2005; 19(4):214-9. PubMed ID: 15703464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet ADP-receptor antagonists for cardiovascular disease: past, present and future.
    Raju NC; Eikelboom JW; Hirsh J
    Nat Clin Pract Cardiovasc Med; 2008 Dec; 5(12):766-80. PubMed ID: 18957959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The thienopyridine derivatives (platelet adenosine diphosphate receptor antagonists), pharmacology and clinical developments.
    Kam PC; Nethery CM
    Anaesthesia; 2003 Jan; 58(1):28-35. PubMed ID: 12492666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.